PCOS affects an estimated 1 in 5 women in India, yet more than half remain undiagnosed due to limited awareness, delayed consultations, and misconceptions surrounding menstrual and metabolic health. The condition often presents silently—through irregular cycles, weight gain, acne, fertility challenges, or emotional distress—making the role of the clinician crucial in early recognition and sustained management.
Recognizing this significant public-health gap, Stedman Pharmaceuticals has launched the iKnowPCOS initiative: a commitment to strengthening the bridge between women and their healthcare providers. Our goal is to ensure that every patient receives clear, credible, and accessible information that encourages timely consultation and informed decision-making.
Through this campaign, Stedman aspires to reduce the growing burden of undiagnosed PCOS across the country by making evidence-based educational resources more visible and easier for clinicians to share. We aim to support gynecologists with reliable tools that help patients understand their condition, adhere to medical advice, and stay engaged in long-term management.
iKnowPCOS reflects Stedman’s belief that awareness is a form of care—one that begins in the doctor’s chamber and extends into the daily lives of millions of women who deserve early recognition, compassionate guidance, and better health outcomes.
Polycystic Ovary Syndrome PCOS is one of the most common hormonal and metabolic conditions affecting women in India. Understanding its scale helps highlight the need for early recognition and better education.
To reduce the national burden of undiagnosed PCOS by strengthening awareness pathways between women and healthcare providers.
To enable clinicians with reliable patient-education tools that improve recognition, screening, and ongoing self-management of PCOS across India.